Skip to main content
. Author manuscript; available in PMC: 2015 Jan 7.
Published in final edited form as: J AIDS Clin Res. 2014 Jul 7;5:1000323. doi: 10.4172/2155-6113.1000323

Table 1.

Participant characteristics at initial HAART visit, N = 1177.

Characteristic Median (inter-quartile range) or %

Date of HAART initiation February 1998 (March 1997, February 2000)

Cumulative NRTI use-years 3.3 (1.6, 5.1)

  Cumulative zidovudine use-years 1.0 (0.5, 1.9)

  Cumulative stavudine use-years 0.5 (0.0, 1.0)

  Cumulative abacavir use-years 0.0 (0.0, 0.0)

  Cumulative tenofovir use-years 0.0(0.0, 0.0)

Cumulative PI use-years 0.5 (0.2, 0.6)

Cumulative NNRTI use-years 0.0 (0.0, 0.4)

Enrollment Period 1994–1995 91%

Age, yearsa 38.7 (33.6,44.1)

Race/Ethnicity
  African-American 56%
  Hispanic 25%
  White 16%
  Other 2%

Alcohol Use ≥3 drinks/weeka 18%

Cigarette Smokinga
  Current 51%
  Former 22%
  Never 27%

Marijuana usesince last visit 18%

Injection drug, heroin, cocaine, or crack use since last visit 13%

Quality of Lifea 65.5 (48.4, 79.5)

CESD ≥ 16a 49%

Highest education level attained
  Graduated college or higher 8%
  Some College 25%
  Completed High School 31%
  Did not complete high school 37%

Have AIDSa 40%

CD4 cell count, cells/mm3a
  <100 15%
  100–<200 18%
  200–<500 51%
  ≥ 500 15%

log10HIVRNA, copies/mla 4.2 (3.3, 4.8)
a

ascertained from visit immediately prior to initiating HAART